Search research articles
Contact Us
Filters
Showing results (11-20 of 101) with videos related to
Page
of 11
Sort By:
Hematology (Amsterdam, Netherlands)
|
March 25, 2024
Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice
Elio Haroun, Seah H Lim, Dibyendu Dutta
Hematology (Amsterdam, Netherlands)
|
June 16, 2001
Malignancy: Idiotypic Immune Targeting of Multiple Myeloma
SEAH H. Lim, YUE-JIN Wen, MIN Ling
Journal of Breath Research
|
February 22, 2018
Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications
Dibyendu Dutta, Ngee S Chong, Seah H Lim
Journal of Translational Medicine
|
December 4, 2016
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Vikram M Raghunathan, Iris Sheng, Seah H Lim
Molecular Therapy Oncolytics
|
December 2, 2021
Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering
Maria Poplawska, Dibyendu Dutta, Yichun Lee, et al.
The American Journal of Hospice & Palliative Care
|
March 10, 2007
Medical condition is related to treatment preference in cancer patients: implications for quality assessment
James E Rohrer, Seah H Lim, Frank Andrew Bock
American Journal of Hematology
|
August 27, 2017
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
Rory M Shallis, Christopher M Terry, Seah H Lim
Annals of Hematology
|
August 4, 2011
Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine
Seah H Lim, Srinivas Pathapati, James Langevin, et al.
Clinical Nephrology
|
February 10, 2018
Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman disease
Nathan Calabro, Kammi Henriksen, Seah H Lim, et al.
Leukemia & Lymphoma
|
November 12, 2010
A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine
Seah H Lim, John Mcmahan, Jian Zhang, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 101) with videos related to
Sort By:
Page
of 11
Hematology (Amsterdam, Netherlands)
|
March 25, 2024
Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice
Elio Haroun, Seah H Lim, Dibyendu Dutta
Hematology (Amsterdam, Netherlands)
|
June 16, 2001
Malignancy: Idiotypic Immune Targeting of Multiple Myeloma
SEAH H. Lim, YUE-JIN Wen, MIN Ling
Journal of Breath Research
|
February 22, 2018
Endogenous volatile organic compounds in acute myeloid leukemia: origins and potential clinical applications
Dibyendu Dutta, Ngee S Chong, Seah H Lim
Journal of Translational Medicine
|
December 4, 2016
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Vikram M Raghunathan, Iris Sheng, Seah H Lim
Molecular Therapy Oncolytics
|
December 2, 2021
Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering
Maria Poplawska, Dibyendu Dutta, Yichun Lee, et al.
The American Journal of Hospice & Palliative Care
|
March 10, 2007
Medical condition is related to treatment preference in cancer patients: implications for quality assessment
James E Rohrer, Seah H Lim, Frank Andrew Bock
American Journal of Hematology
|
August 27, 2017
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
Rory M Shallis, Christopher M Terry, Seah H Lim
Annals of Hematology
|
August 4, 2011
Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine
Seah H Lim, Srinivas Pathapati, James Langevin, et al.
Clinical Nephrology
|
February 10, 2018
Successful use of rituximab in glomerular basement membrane nephritis associated with HIV interstitial nephritis secondary to Castleman disease
Nathan Calabro, Kammi Henriksen, Seah H Lim, et al.
Leukemia & Lymphoma
|
November 12, 2010
A phase II study of low dose intravenous clofarabine for elderly patients with myelodysplastic syndrome who have failed 5-azacytidine
Seah H Lim, John Mcmahan, Jian Zhang, et al.
Page
of 11